EXPANDING USES OF OCTREOTIDE

被引:9
作者
MATON, PN
机构
来源
BAILLIERES CLINICAL GASTROENTEROLOGY | 1994年 / 8卷 / 02期
关键词
D O I
10.1016/0950-3528(94)90007-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
This chapter reviews the therapeutic use of octreotide in a variety of pancreatic disorders, including acute pancreatitis, in the prevention of postoperative and post-ERCP pancreatitis, in the control of postoperative pancreatic fistulae, and in chronic pancreatitis for the control of pain and of pseudocysts and ascites. The review also discusses the use of octreotide in intestinal disorders of motility, gastrointestinal bleeding, intestinal fistulae and refractory diarrhoea, including the diarrhoeas of AIDS, diabetes, short gut, chemotherapy, ileostomy and gastric surgery. The use of octreotide in neuroendocrine tumours, both for therapy and diagnostic imaging, is reviewed briefly. The paucity of adequately controlled studies in many of these situations is indicated and the potential usefulness of octreotide estimated. © 1994.
引用
收藏
页码:321 / 337
页数:17
相关论文
共 120 条
[1]   TREATMENT OF PANCREATIC FISTULA WITH THE SOMATOSTATIN ANALOG SMS 201-995 [J].
AHREN, B ;
TRANBERG, KG ;
BENGMARK, S .
BRITISH JOURNAL OF SURGERY, 1988, 75 (07) :718-718
[2]   GASTROENTEROPANCREATIC ENDOCRINE TUMORS - EFFECT OF SANDOSTATIN(R) ON TUMOR-GROWTH [J].
ARNOLD, R ;
BENNING, R ;
NEUHAUS, C ;
ROLWAGE, M ;
TRAUTMANN, ME .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (09) :116-118
[3]  
BANK S, 1987, GASTROENTEROLOGY, V92, P1304
[4]   OCTREOTIDE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN CONDITIONS ASSOCIATED WITH EXCESSIVE PEPTIDE SECRETION [J].
BATTERSHILL, PE ;
CLISSOLD, SP .
DRUGS, 1989, 38 (05) :658-702
[5]   CONTROLLED TRIAL OF HIGH-DOSE OCTREOTIDE IN TREATMENT OF ACUTE-PANCREATITIS - EVIDENCE OF IMPROVEMENT IN DISEASE SEVERITY [J].
BEECHEYNEWMAN, N .
DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (04) :644-647
[6]   THE SOMATOSTATIN ANALOG OCTREOTIDE IN THE MANAGEMENT OF THE SECRETORY DIARRHEA OF THE ACUTE INTESTINAL GRAFT-VERSUS-HOST DISEASE IN A PATIENT AFTER BONE-MARROW TRANSPLANTATION [J].
BIANCO, JA ;
HIGANO, C ;
SINGER, J ;
APPELBAUM, FR ;
MCDONALD, GB .
TRANSPLANTATION, 1990, 49 (06) :1194-1195
[7]   DOES THE SOMATOSTATIN ANALOG OCTREOTIDE PROTECT AGAINST ERCP INDUCED PANCREATITIS [J].
BINMOELLER, KF ;
HARRIS, AG ;
DUMAS, R ;
GRIMALDI, C ;
DELMONT, JP .
GUT, 1992, 33 (08) :1129-1133
[8]   TREATMENT OF SMALL INTESTINAL FISTULAS WITH OCTREOTIDE, A SOMATOSTATIN ANALOG [J].
BOIKE, GM ;
SIGHTLER, SE ;
AVERETTE, HE .
JOURNAL OF SURGICAL ONCOLOGY, 1992, 49 (01) :63-65
[9]   PREVENTION OF PANCREATIC REACTIONS BY BOLUS SOMATOSTATIN ADMINISTRATION IN PATIENTS UNDERGOING ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY AND ENDOSCOPIC SPHINCTEROTOMY [J].
BORDAS, JM ;
TOLEDO, V ;
MONDELO, F ;
RODES, J .
HORMONE RESEARCH, 1988, 29 (2-3) :106-108
[10]   ROLE OF OCTREOTIDE IN THE PREVENTION OF POSTOPERATIVE COMPLICATIONS FOLLOWING PANCREATIC RESECTION [J].
BUCHLER, M ;
FRIESS, H ;
KLEMPA, I ;
HERMANEK, P ;
SULKOWSKI, U ;
BECKER, H ;
SCHAFMAYER, A ;
BACA, I ;
LORENZ, D ;
MEISTER, R ;
KREMER, B ;
WAGNER, P ;
WITTE, J ;
ZURMAYER, EL ;
SAEGER, HD ;
RIECK, B ;
DOLLINGER, P ;
GLASER, K ;
TEICHMANN, R ;
KONRADT, J ;
GAUS, W ;
DENNLER, HJ ;
WELZEL, D ;
BEGER, HG .
AMERICAN JOURNAL OF SURGERY, 1992, 163 (01) :125-131